Reading a trial result
Endpoints, statistical significance, and the traps in topline data.
A trial 'works' only if it meets its pre-specified primary endpoint with statistical significance. The details matter as much as the headline.
Key terms
- Primary endpoint — the main pre-defined measure of success; missing it usually sinks the stock regardless of anything else.
- Secondary endpoints — supporting measures; nice to have, not sufficient on their own.
- Statistical significance (p-value) — p < 0.05 is the common bar; it means the result is unlikely to be chance.
- Effect size — how big the benefit is, not just whether it's significant; a 'significant' but tiny benefit can still disappoint.
- Safety / tolerability — adverse events can sink an otherwise positive trial.
Common traps
- Hitting a secondary while missing the primary — often spun positively, but usually a fail.
- 'Trends toward significance' — i.e. it missed.
- Subgroup wins — post-hoc subgroups are hypothesis-generating, not confirmatory.
Educational only — not financial advice.